Abstract
Prenatal antidepressant use is widespread. Observational studies have investigated the neonatal effects of prenatal antidepressant exposure with inconclusive results. We aimed to comprehensively investigate the associations between prenatal antidepressant exposure and the most commonly studied adverse neonatal outcomes: preterm birth, birthweight, poor neonatal adaptation, persistent pulmonary hypertension of the neonate (PPHN), neonatal admission and congenital malformations. We included 45,590singletons (born 1997-2015) whose mothers used antidepressants within one year before pregnancy. Children were categorised into two groups: continuation (antidepressant use before and during pregnancy) or discontinuation (antidepressant use before but not during pregnancy). We applied random-effects logistic and linear regressions, adjusting for covariates. After adjusting for confounders, prenatal antidepressant exposure was associated with a 2.3day (95% CI -2.9; -2.0) decrease in gestational age and a 51g (95% CI -62g; -41g) decrease in birthweight. The continuation group was at increased risk for moderate-to-late preterm birth (32-37weeks) (aOR=1.43; 95%CI 1.33; 1.55), moderately low birthweight (1500-2499g) (aOR=1.28; 95%CI 1.17; 1.41), postnatal adaptation syndrome (aOR=2.59; 95%CI 1.87; 3.59) and neonatal admission (aOR=1.52; 95%CI 1.44; 1.60) compared to the discontinuation group. Prenatal antidepressant exposure was associated with small decreases in gestational age and birthweight, as well as higher risk for moderate-to-late preterm birth, moderately low birthweight, neonatal admission and postnatal adaptation syndrome. No differences in risk were found for PPHN, or congenital malformations. The causality of the observed associations cannot be established due to the potential for unmeasured residual confounding linked to the underlying disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.